INSPIREMD INC. - COMMO

InspireMD Presents Positive 30-Day Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial at VIVA23

01 11 2023 14:19:15 提供 Nasdaq GlobeNewswire

InspireMD to Report Third Quarter 2023 Financial Results and Provide Corporate Business Update on Monday, November 6th

30 10 2023 09:21:50 提供 Nasdaq GlobeNewswire

InspireMD Supports CMS’ Final National Coverage Determination (NCD) Expanding Coverage of Carotid Stenting (CAS) to Include Both Asymptomatic and Standard Risk Patients

12 10 2023 07:00:00 提供 Nasdaq GlobeNewswire

InspireMD Announces Senior Leadership Changes to Support Commercial Growth Initiatives

03 10 2023 07:00:00 提供 Nasdaq GlobeNewswire

InspireMD Announces Abstract of 30-Day Results from the C-Guardians U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at VIVA23

31 8 2023 08:00:00 提供 Nasdaq GlobeNewswire

InspireMD Reports Second Quarter 2023 Financial Results and Provides Business Update

08 8 2023 07:00:01 提供 Nasdaq GlobeNewswire

InspireMD Announces Completion of Enrollment in C-Guardians U.S. Investigational Device Exemption (IDE) Clinical Trial

26 6 2023 08:00:00 提供 Nasdaq GlobeNewswire

InspireMD Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

18 5 2023 08:00:01 提供 Nasdaq GlobeNewswire

InspireMD Reports First Quarter 2023 Financial Results and Provides Business Update

16 5 2023 07:00:01 提供 Nasdaq GlobeNewswire

InspireMD Announces Private Placement of Up to $113.6 Million

15 5 2023 08:00:01 提供 Nasdaq GlobeNewswire

InspireMD Announces May 16, 2023 as New Date for First Quarter 2023 Results Conference Call and Webcast

12 5 2023 16:05:00 提供 Nasdaq GlobeNewswire

InspireMD Announces May 15th as New Date for First Quarter 2023 Financial Results and Corporate Business Update

05 5 2023 08:00:00 提供 Nasdaq GlobeNewswire

InspireMD Announces Successful First-in-Human Procedure Utilizing CGuard Prime, its Next Generation Carotid Artery Stent (CAS) Platform

01 5 2023 08:00:02 提供 Nasdaq GlobeNewswire

InspireMD to Report First Quarter 2023 Financial Results on May 9, 2023, and Provide Corporate Business Update

27 4 2023 08:00:01 提供 Nasdaq GlobeNewswire

InspireMD Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Business Update

30 3 2023 07:00:01 提供 Nasdaq GlobeNewswire

InspireMD Announces Promotion of Andrea Tommasoli to Chief Operating Officer

20 3 2023 08:00:01 提供 Nasdaq GlobeNewswire

InspireMD to Report Fourth Quarter and Full-Year 2022 Financial Results on March 30, 2023, and Provide a Corporate Business Update

02 3 2023 08:00:00 提供 Nasdaq GlobeNewswire

InspireMD Announces Hiring of Medical Device Commercial Veteran Shane Gleason as General Manager of North America and VP of Global Marketing

14 2 2023 08:00:01 提供 Nasdaq GlobeNewswire

InspireMD Reports Third Quarter 2022 Financial Results and Provides Business Update

08 11 2022 07:00:03 提供 Nasdaq GlobeNewswire

InspireMD to Report Third Quarter 2022 Financial Results on November 8, 2022, and Provide Corporate Business Update

25 10 2022 08:00:01 提供 Nasdaq GlobeNewswire